The latest update is out from OneMedNet ( (ONMD) ).
On February 25, 2025, OneMedNet Corporation expanded its Board of Directors to nine members and appointed Dr. Kenneth Alleyne as a Class III Director and a member of the Audit Committee. Dr. Alleyne is recognized as an independent director under Nasdaq requirements and meets SEC standards for audit committee independence. His appointment does not involve any family or related party transactions.
More about OneMedNet
YTD Price Performance: -35.25%
Average Trading Volume: 148,053
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $25.19M
See more insights into ONMD stock on TipRanks’ Stock Analysis page.